Financial Constraints to Molecular Biomarker TestingVideo Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library
Drs. David Rimm and Roy Herbst discuss the challenges of reimbursement by payers and the costs to pathology department of molecular biomarker testing, especially immunohistochemistry and DNA testing.
Managing Costs in Oncology Care
Dr. Boccia talks about the importance of controlling costs in the current environment and how the bioT3 testing approach can help compared to other options.
Targeted Therapies and their Impact on Melanoma
Dr. Steve Oâ€™Day works with melanoma and has seen great breakthroughs in targeted therapies and their impact on the disease.